Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Plasma proteome profiling discovers novel proteins associated with non‐alcoholic fatty liver disease
Lili Niu, Philipp E. Geyer, Nicolai J. Wewer Albrechtsen, et al.
Molecular Systems Biology (2019) Vol. 15, Iss. 3
Open Access | Times Cited: 229

Showing 1-25 of 229 citing articles:

Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection
Christoph B. Messner, Vadim Demichev, Daniel Wendisch, et al.
Cell Systems (2020) Vol. 11, Iss. 1, pp. 11-24.e4
Open Access | Times Cited: 534
Robust, reproducible and quantitative analysis of thousands of proteomes by micro-flow LC–MS/MS
Yangyang Bian, Runsheng Zheng, Florian Bayer, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 284
Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease
Jakob M. Bader, Philipp E. Geyer, Johannes Müller, et al.
Molecular Systems Biology (2020) Vol. 16, Iss. 6
Open Access | Times Cited: 216
A knowledge graph to interpret clinical proteomics data
Alberto Santos, Ana R. Colaço, Annelaura Bach Nielsen, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 5, pp. 692-702
Open Access | Times Cited: 190
Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments
Cheng Peng, Alastair G. Stewart, Owen L. Woodman, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 178
Noninvasive proteomic biomarkers for alcohol-related liver disease
Lili Niu, Maja Thiele, Philipp E. Geyer, et al.
Nature Medicine (2022) Vol. 28, Iss. 6, pp. 1277-1287
Open Access | Times Cited: 175
Mass Spectrometry-Based Plasma Proteomics: Considerations from Sample Collection to Achieving Translational Data
Vera Ignjatović, Philipp E. Geyer, Krishnan K. Palaniappan, et al.
Journal of Proteome Research (2019) Vol. 18, Iss. 12, pp. 4085-4097
Open Access | Times Cited: 168
Multiplatform Approach for Plasma Proteomics: Complementarity of Olink Proximity Extension Assay Technology to Mass Spectrometry-Based Protein Profiling
Agnese Petrera, Christine von Toerne, Jennifer Behler, et al.
Journal of Proteome Research (2020) Vol. 20, Iss. 1, pp. 751-762
Open Access | Times Cited: 144
Urinary proteome profiling for stratifying patients with familial Parkinson’s disease
Sebastian Virreira Winter, Özge Karayel, Maximilian T. Strauss, et al.
EMBO Molecular Medicine (2021) Vol. 13, Iss. 3
Open Access | Times Cited: 116
Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s disease
Özge Karayel, Sebastian Virreira Winter, Shalini Padmanabhan, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 6, pp. 100661-100661
Open Access | Times Cited: 106
MS-Based Proteomics of Body Fluids: The End of the Beginning
Jakob M. Bader, Vincent Albrecht, Matthias Mann
Molecular & Cellular Proteomics (2023) Vol. 22, Iss. 7, pp. 100577-100577
Open Access | Times Cited: 62
Plasma proteomic profiles predict individual future health risk
Jia You, Yu Guo, Yi Zhang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 46
Profiling mouse brown and white adipocytes to identify metabolically relevant small ORFs and functional microproteins
Thomas F. Martínez, Sally Lyons‐Abbott, Angie L. Bookout, et al.
Cell Metabolism (2023) Vol. 35, Iss. 1, pp. 166-183.e11
Open Access | Times Cited: 44
Decoding the glycoproteome: a new frontier for biomarker discovery in cancer
Kai He, Maryam Baniasad, Hyunwoo Kwon, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 20
Nano–Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection
Yuan Liu, Junqing Wang, Qingqing Xiong, et al.
Accounts of Chemical Research (2020) Vol. 54, Iss. 2, pp. 291-301
Closed Access | Times Cited: 124
The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease
Nikolaos Perakakis, Konstantinos Stefanakis, Christos S. Mantzoros
Metabolism (2020) Vol. 111, pp. 154320-154320
Open Access | Times Cited: 119
NAguideR: performing and prioritizing missing value imputations for consistent bottom-up proteomic analyses
Shisheng Wang, Wenxue Li, Liqiang Hu, et al.
Nucleic Acids Research (2020) Vol. 48, Iss. 14, pp. e83-e83
Open Access | Times Cited: 116
Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism
Songsong Wang, Feiya Sheng, Liang Zou, et al.
Journal of Advanced Research (2021) Vol. 34, pp. 109-122
Open Access | Times Cited: 91
Integrative analysis of cell state changes in lung fibrosis with peripheral protein biomarkers
Christoph H. Mayr, Lukas M. Simon, Gabriela Leuschner, et al.
EMBO Molecular Medicine (2021) Vol. 13, Iss. 4
Open Access | Times Cited: 84
Dynamic human liver proteome atlas reveals functional insights into disease pathways
Lili Niu, Philipp E. Geyer, Rajat Gupta, et al.
Molecular Systems Biology (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 46
Targeting of Scavenger Receptors Stabilin-1 and Stabilin-2 Ameliorates Atherosclerosis by a Plasma Proteome Switch Mediating Monocyte/Macrophage Suppression
Calin-Petru Manta, Thomas Leibing, Mirco Friedrich, et al.
Circulation (2022) Vol. 146, Iss. 23, pp. 1783-1799
Open Access | Times Cited: 46
Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches
Eirini Martinou, Marinos Pericleous, Irena Stefanova, et al.
Diagnostics (2022) Vol. 12, Iss. 2, pp. 407-407
Open Access | Times Cited: 45
From MAFLD to hepatocellular carcinoma and everything in between
Sarah Da Won Bae, Jacob George, Liang Qiao
Chinese Medical Journal (2022) Vol. 135, Iss. 5, pp. 547-556
Open Access | Times Cited: 43
Enhanced Competition at the Nano–Bio Interface Enables Comprehensive Characterization of Protein Corona Dynamics and Deep Coverage of Proteomes
Shadi Ferdosi, Alexey Stukalov, Moaraj Hasan, et al.
Advanced Materials (2022) Vol. 34, Iss. 44
Open Access | Times Cited: 43
Page 1 - Next Page

Scroll to top